Portland Global Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Portland Global Advisors's ABBV Position: Q1 2026 in Review
Portland Global Advisors sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 989 shares — an estimated $226K sold.
Portland Global Advisors first reported a position in ABBV in Q3 2017 and held it in 23 quarters. The position peaked at $395K in Q2 2020. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Portland Global Advisors reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- Portland Global Advisors sold 989 AbbVie shares in Q1 2026, an estimated $226K.
- Portland Global Advisors first reported a position in AbbVie in Q3 2017 and held it in 23 quarters.
- Portland Global Advisors's AbbVie position peaked at $395K in Q2 2020.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Portland Global Advisors's 13F filing for Q1 2026, filed 11 May 2026.